CGTX
Income statement / Annual
Last year (2023), Cognition Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Cognition Therapeutics, Inc.'s net income was -$25.79 M.
See Cognition Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$252,000.00 |
$235,000.00 |
$93,000.00 |
$98,000.00 |
$81,000.00 |
| Gross Profit |
-$252,000.00 |
-$235,000.00 |
-$93,000.00 |
-$98,000.00 |
-$81,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$37.20 M
|
$30.32 M
|
$18.57 M
|
$12.89 M
|
$14.38 M
|
| General & Administrative
Expenses |
$13.53 M
|
$13.23 M
|
$10.03 M
|
$4.52 M
|
$3.45 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.53 M
|
$13.23 M
|
$10.03 M
|
$4.52 M
|
$3.45 M
|
| Other Expenses |
$0.00 |
-$22.22 M |
-$17.45 M |
-$10.86 M |
-$13.16 M |
| Operating Expenses |
$50.72 M |
$21.33 M |
$11.15 M |
$6.55 M |
$4.67 M |
| Cost And Expenses |
$50.72 M |
$21.33 M |
$11.15 M |
$6.55 M |
$4.67 M |
| Interest Income |
$27,000.00 |
$22.22 M |
$17.45 M |
$10.86 M |
$13.16 M |
| Interest Expense |
$0.00 |
$28,000.00 |
$893,000.00 |
$1.75 M |
$1.02 M |
| Depreciation &
Amortization |
$96,000.00
|
$235,000.00
|
$93,000.00
|
$98,000.00
|
$81,000.00
|
| EBITDA |
-$25.51 M
|
-$21.13 M
|
-$13.38 M
|
-$5.99 M
|
-$3.50 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$24.94 M
|
$22.15 M
|
$16.88 M
|
$9.57 M
|
$12.99 M
|
| Income Before Tax |
-$25.79 M |
-$21.40 M |
-$11.72 M |
-$7.84 M |
-$4.84 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$22.15 M |
-$1.43 M |
$2.23 M |
$2.11 M |
| Net Income |
-$25.79 M |
$757,000.00 |
-$10.29 M |
-$10.07 M |
-$6.95 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.86 |
0.0261 |
-0.46 |
-0.46 |
-0.32 |
| EPS Diluted |
-0.86 |
0.0261 |
-0.46 |
-0.46 |
-0.32 |
| Weighted Average Shares
Out |
$29.99 M
|
$28.99 M
|
$22.23 M
|
$21.94 M
|
$21.94 M
|
| Weighted Average Shares
Out Diluted |
$30.03 M
|
$28.99 M
|
$22.23 M
|
$21.94 M
|
$21.94 M
|
| Link |
|
|
|
|
|
